» Articles » PMID: 21438003

Increased Level of Serum Homocysteine in Vitiligo

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2011 Mar 26
PMID 21438003
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitiligo is an acquired depigmenting disorder caused by the destruction of melanocytes. The exact etiopathogenesis and mechanisms of vitiligo are not fully understood. Vitamin B12 and folic acid levels are decreased in vitiligo, which are the important cofactors required in the metabolism of Homocysteine (Hcy). Consequently, Hcy level increases in the circulation. Therefore, it is possible that increased Hcy plays a role in melanocytes destruction. The aim was to study for any association of vitiligo with serum Hcy level.

Method: A total of 30 vitiligo patients of both sexes and 30 control subjects were enrolled in this study. Sera from patients and controls were assayed for Hcy by Enzyme immunoassay. The collected data were analyzed by SPSS version-16.

Results: The mean serum level of Hcy was significantly higher in patients with vitiligo as compared with healthy controls and its level was high in male patients as compared with female patients. The Hcy level in vegetarian patients was significantly higher as compared with nonvegetarian patients. The Hcy level was also significantly higher in active vitiligo patients as compared with stable vitiligo patients.

Conclusion: An increased serum Hcy may be a precipitating factor for vitiligo in the predisposed individuals. Serum Hcy is related to the gender of patients, activity of disease, and dietary habits of vitiligo patients.

Citing Articles

Markers of Metabolic Abnormalities in Vitiligo Patients.

Papaccio F, Ottaviani M, Truglio M, DArino A, Caputo S, Pacifico A Int J Mol Sci. 2024; 25(18).

PMID: 39337683 PMC: 11432710. DOI: 10.3390/ijms251810201.


Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence.

Liang X, Guo F, Zhang M, Wang C, Lin N, Liu L Ann Med. 2024; 56(1):2326297.

PMID: 39300810 PMC: 11418058. DOI: 10.1080/07853890.2024.2326297.


Vitiligo and insulin resistance as a component of metabolic syndrome: an analysis.

Tekielak A, Pietrauszka K, Miziolek B, Bergler-Czop B Postepy Dermatol Alergol. 2023; 40(4):529-533.

PMID: 37692261 PMC: 10485765. DOI: 10.5114/ada.2023.126871.


A Hospital-Based Case-Control Study on Raised Homocysteine Level in Vitiligo Patients and Its Association With Disease Severity.

Choudhary N, Patel N, Raghuwanshi A, Choudhary N, Agrawal S Cureus. 2023; 15(2):e34772.

PMID: 36909125 PMC: 10005420. DOI: 10.7759/cureus.34772.


Where Microneedle Meets Biomarkers: Futuristic Application for Diagnosing and Monitoring Localized External Organ Diseases.

Himawan A, Vora L, Permana A, Sudir S, Nurdin A, Nislawati R Adv Healthc Mater. 2022; 12(5):e2202066.

PMID: 36414019 PMC: 11468661. DOI: 10.1002/adhm.202202066.


References
1.
Reish O, Townsend D, Berry S, Tsai M, King R . Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1995; 57(1):127-32. PMC: 1801223. View

2.
Guilland J, Favier A, Potier de Courcy G, Galan P, Hercberg S . [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data]. Pathol Biol (Paris). 2003; 51(2):101-10. DOI: 10.1016/s0369-8114(03)00104-4. View

3.
Hu C, SHAO J, Yan J, Fan Q, Liu Z, Tian C . [Study on the distribution of serum homocysteine and on multi-stepwise regression analysis of the associated factors in the population of community areas in Wuhan]. Zhonghua Liu Xing Bing Xue Za Zhi. 2005; 25(11):945-8. View

4.
MINET J, Bisse E, Aebischer C, Beil A, Wieland H, Lutschg J . Assessment of vitamin B-12, folate, and vitamin B-6 status and relation to sulfur amino acid metabolism in neonates. Am J Clin Nutr. 2000; 72(3):751-7. DOI: 10.1093/ajcn/72.3.751. View

5.
Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G . Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol. 1996; 105(1):84-8. PMC: 2200479. DOI: 10.1046/j.1365-2249.1996.d01-727.x. View